These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 24061467)

  • 1. Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma.
    Chou SW; Chang HH
    Cancer Lett; 2024 Apr; 588():216617. PubMed ID: 38311055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-center Study.
    Sakurai Y; Iwasaki F; Hirose A; Matsumoto N; Miyagawa N; Keino D; Yokosuka T; Hamanoue S; Yanagimachi M; Shiomi M; Goto S; Tanaka M; Tanaka Y; Nozawa K; Goto H
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):233-240. PubMed ID: 38691057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.
    Jan N; Sofi S; Qayoom H; Shabir A; Haq BU; Macha MA; Almilaibary A; Mir MA
    Heliyon; 2024 Feb; 10(3):e24670. PubMed ID: 38314272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models.
    Mainetti LE; Rico MJ; Kaufman CD; Grillo MC; Guercetti J; Baglioni MV; Del Giúdice A; Capitani MC; Fusini M; Rozados VR; Scharovsky OG
    Oncotarget; 2020 Aug; 11(32):3048-3060. PubMed ID: 32850009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
    Ritchlin C; Rahman P; Kavanaugh A; McInnes IB; Puig L; Li S; Wang Y; Shen YK; Doyle MK; Mendelsohn AM; Gottlieb AB;
    Ann Rheum Dis; 2014 Jun; 73(6):990-9. PubMed ID: 24482301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAISE - rheumatoid arthritis independent Swiss treatment expectations and outcome: results for the abatacept subpopulation.
    Dudler J; Tuerk R; Handschin T; Forster A
    Swiss Med Wkly; 2013; 143():w13849. PubMed ID: 24318979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials.
    Ioakeim-Skoufa I; Tobajas-Ramos N; Menditto E; Aza-Pascual-Salcedo M; Gimeno-Miguel A; Orlando V; González-Rubio F; Fanlo-Villacampa A; Lasala-Aza C; Ostasz E; Vicente-Romero J
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies.
    Banchi M; Fini E; Crucitta S; Bocci G
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature.
    Carcamo B; Francia G
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic Chemotherapy.
    Cazzaniga ME; Cordani N; Capici S; Cogliati V; Riva F; Cerrito MG
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
    Boyer A; Pasquier E; Tomasini P; Ciccolini J; Greillier L; Andre N; Barlesi F; Mascaux C
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29540495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
    Pramanik R; Agarwala S; Gupta YK; Thulkar S; Vishnubhatla S; Batra A; Dhawan D; Bakhshi S
    JAMA Oncol; 2017 Sep; 3(9):1222-1227. PubMed ID: 28384657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.
    Rosé A; André N; Rozados VR; Mainetti LE; Menacho Márquez M; Rico MJ; Schaiquevich P; Villarroel M; Gregianin L; Graupera JM; García WG; Epelman S; Alasino C; Alonso D; Chantada G; Scharovsky OG
    Ecancermedicalscience; 2016; 10():672. PubMed ID: 27610198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells.
    Winter U; Mena HA; Negrotto S; Arana E; Pascual-Pasto G; Laurent V; Suñol M; Chantada GL; Carcaboso AM; Schaiquevich P
    PLoS One; 2016; 11(7):e0160094. PubMed ID: 27467588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.
    Bouche G; André N; Banavali S; Berthold F; Berruti A; Bocci G; Brandi G; Cavallaro U; Cinieri S; Colleoni M; Curigliano G; Di Desidero T; Eniu A; Fazio N; Kerbel R; Hutchinson L; Ledzewicz U; Munzone E; Pasquier E; Graciela Scharovsky O; Shaked Y; Stěrba J; Villalba M; Bertolini F
    Ecancermedicalscience; 2014; 8():463. PubMed ID: 25228919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomics: towards personalized chemotherapy?
    André N; Carré M; Pasquier E
    Nat Rev Clin Oncol; 2014 Jul; 11(7):413-31. PubMed ID: 24913374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
    Traore F; Togo B; Pasquier E; Dembélé A; André N
    Indian J Cancer; 2013; 50(3):250-3. PubMed ID: 24061467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01.
    Fousseyni T; Diawara M; Pasquier E; André N
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):31-4. PubMed ID: 21164360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metro-SMHOP 01: Metronomics combination with cyclophosphamide-etoposide and valproic acid for refractory and relapsing pediatric malignancies.
    El Kababri M; Benmiloud S; Cherkaoui S; El Houdzi J; Maani K; Ansari N; Khoubila N; Kili A; El Khorassani M; Madani A; Tazi MA; Ahid S; Hessissen L; Quessar A; Harif M; Khattab M; André N
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28508. PubMed ID: 32658380
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.